Forebyggelse af herpes zoster med vaccination

Kristian Kofoed; Finn Rønholt; Jan Gerstoft; Carsten Sand

Forebyggelse af herpes zoster med vaccination

Kristian Kofoed, Finn Rønholt, Jan Gerstoft, Carsten Sand

1 Citationer (Scopus)

Abstract

Herpes zoster (HZ) and post-herpetic neuralgia (PHN) are frequently occurring diseases in elderly and in immuno-compromised persons. The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. Vaccination has been shown to halve the risk of HZ, and the risk of PHN is reduced by two thirds in people = 60 years. The vaccine is approved for persons aged = 50 years. However, the clinical efficacy of the vaccine is best studied in people aged = 60 years. The vaccine has so far not shown any serious side-effects.

Bidragets oversatte titel	[Prevention of herpes zoster by vaccination]
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	173
Udgave nummer	2
Sider (fra-til)	110-4
Antal sider	5
ISSN	0041-5782
Status	Udgivet - 10 jan. 2011

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

@article{63e49e0c637e49b9ab9881e3837c8420,

title = "Forebyggelse af herpes zoster med vaccination",

abstract = "Herpes zoster (HZ) and post-herpetic neuralgia (PHN) are frequently occurring diseases in elderly and in immuno-compromised persons. The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. Vaccination has been shown to halve the risk of HZ, and the risk of PHN is reduced by two thirds in people = 60 years. The vaccine is approved for persons aged = 50 years. However, the clinical efficacy of the vaccine is best studied in people aged = 60 years. The vaccine has so far not shown any serious side-effects.",

author = "Kristian Kofoed and Finn R{\o}nholt and Jan Gerstoft and Carsten Sand",

year = "2011",

month = jan,

day = "10",

language = "Dansk",

volume = "173",

pages = "110--4",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "2",

}

TY - JOUR

T1 - Forebyggelse af herpes zoster med vaccination

AU - Kofoed, Kristian

AU - Rønholt, Finn

AU - Gerstoft, Jan

AU - Sand, Carsten

PY - 2011/1/10

Y1 - 2011/1/10

N2 - Herpes zoster (HZ) and post-herpetic neuralgia (PHN) are frequently occurring diseases in elderly and in immuno-compromised persons. The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. Vaccination has been shown to halve the risk of HZ, and the risk of PHN is reduced by two thirds in people = 60 years. The vaccine is approved for persons aged = 50 years. However, the clinical efficacy of the vaccine is best studied in people aged = 60 years. The vaccine has so far not shown any serious side-effects.

AB - Herpes zoster (HZ) and post-herpetic neuralgia (PHN) are frequently occurring diseases in elderly and in immuno-compromised persons. The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. Vaccination has been shown to halve the risk of HZ, and the risk of PHN is reduced by two thirds in people = 60 years. The vaccine is approved for persons aged = 50 years. However, the clinical efficacy of the vaccine is best studied in people aged = 60 years. The vaccine has so far not shown any serious side-effects.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 173

SP - 110

EP - 114

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 2

ER -

Forebyggelse af herpes zoster med vaccination

Abstract

FN’s Verdensmål

Fingeraftryk

Citationsformater